small molecule microbial hormones drastically alter the expression profiles of 21 antibiotics and other drugs in actinobacteria. For example, avenolide (a butenolide) 22 regulates production of avermectin, derivatives of which are used in the treatment of river 23 blindness and other parasitic diseases. Butenolides and γ-butyrolactones control 24 production of pharmaceutically important secondary metabolites by binding to TetR 25 family transcriptional repressors. Here, we describe a concise, 22-step synthetic strategy 26 for the production of avenolide. We present crystal structures of the butenolide receptor 27 AvaR1 in isolation, and in complex with avenolide, as well as AvaR1 bound to an 28 oligonucleotide derived from its operator. Biochemical studies guided by the co-crystal 29 structures enable identification of 90 new actinobacteria that may be regulated by 30 butenolides, two of which are experimentally verified. These studies provide a foundation 31 for understanding regulation of microbial secondary metabolite production, which may be 32 exploited for the discovery and production of novel medicines. 33 34 35